Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Stereotactic Ablative Radiotherapy for Comprehensive Treatment of 4-10 Oligometastatic Tumors	Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm	Active, not recruiting	Phase 3	2026-09-30		NCT03721341

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)	199
Beatson West of Scotland Cancer Centre	4
British Columbia Cancer - Centre for the North	1
David Palma	6
London Health Sciences Centre	37

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Alfred Health	Melbourne	Australia	2
BC Cancer Agency, Vancouver Island Centre	Victoria	Canada	1
Beatson West of Scotland Cancer Centre	Glasgow	United Kingdom	39
Centre hospitalier de l'Université de Montréal-CHUM	Montreal	Canada	1
Grand River Hospital	Kitchener	Canada	1
Health Sciences North	Greater Sudbury	Canada	25
London Regional Cancer Program of the Lawson Health Research Institute	London	Canada	5
Niagra Health System	St. Catharines	Canada	1
Nova Scotia Health Authortiy	Halifax	Canada	1
Trillium Health Partners-Credit Valley Hospital	Mississauga	Canada	2
University Health Network	Toronto	Canada	50
University Hospital of Zürich	Zurich	Switzerland	6
VU University Medical Centre	Amsterdam	Netherlands	1
Western General Hospital	Edinburgh	United Kingdom	52